Testing chloroquine added to tuberculosis treatment for safety
Part of Infections clinical trials.
This Phase 1 study tests how safe and tolerable chloroquine is when given alongside standard tuberculosis medicine. It mainly involves healthy volunteers and helps researchers understand side effects and safe dosing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are willing to sign consent for the study, including optional genetic testing
- You are between 18 and 50 years old
- If you can become pregnant: use highly effective birth control during the study and for 8 months after the last dose
- You are not pregnant or breastfeeding
- You have no known allergy or contraindication to chloroquine or related medicines (including G6PD deficiency)
- You meet key safety checks (vitals, ECG/heart tracing, and blood tests) and have no major medical or mental health condition that could affect safety
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
This trial tests whether a combination of pyrazinamide and hydroxychloroquine, guided by artificial intelligence, works better than the standard 4-drug regimen for drug-sensitive pulmonary tuberculosis. If effective, this could shorten treatment or reduce side effects.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests a shorter treatment for drug-resistant tuberculosis (TB) using the medicine Pretomanid. It aims to find a more manageable cure for people whose TB does not respond to the standard first-line drug, rifampicin.
This study is testing new combinations of drugs to treat tuberculosis (TB) in the lungs. It aims to find a more effective and shorter treatment, and you may benefit from receiving these new drugs while helping advance TB research.
This trial tests two drugs, metformin and N-acetylcysteine, to see if they can help your lungs work better after you finish tuberculosis treatment. You may join if you have active TB with lung damage and are starting standard TB therapy.
Hear when a new Tuberculosis Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.